课题基金 / 基金详情

Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair

Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
用于糖尿病伤口修复的工程可注射微孔水凝胶
批准号:
10460610
负责人:
Donald Richieri Griffin
金额:
$64.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-02 至 2026-06-30

项目摘要

项目成果

Donald Richieri Griffin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY In this proposal, we aim to engineer a biomaterial scaffold to accelerate diabetic wound closure by improving upon a new sub-class of hydrogel biomaterials we have invented called Microporous Annealed Particle gel or MAP gel. MAP gels are composed of microscopic spherical building blocks made using microfluidic generation and assembled in situ to form a stable MAP scaffold. MAP scaffolds have been shown to improve tissue healing in both skin and brain through a porosity-dependent reduction in wound inflammation and promotion of cell/tissue integration. We are focusing on material improvements to counter three known difficulties for material-based treatment of diabetic wounds: abnormally high immune activation, increased degradative microenvironment, and diminished new tissue generation. Specifically, we have identified three MAP properties that we can independently modulate for scientific optimization: pore geometry (known immunomodulatory parameter), degradability (premature material degradation results in loss of porous geometry), and heterogeneous heparin “micro-islands” (a novel material strategy we have developed to improve intra- scaffold angiogenesis). We hypothesize that investigating and optimizing each property individually will accelerate diabetic wound closure and, finally, that the optimized properties can be combined synergistically. We will evaluate and optimize each material property using the following characterization workflow: in vitro property quantification (property-dependent), in vitro cell response (survival, proliferation, and migration), in vivo immune response (analysis by FACS), in vivo material degradation (analysis by histology), and in vivo tissue healing/regeneration (analysis by immunohistology). Our studies focus on the diabetic wound environment through use of dermal cell lines in vitro and a diabetic mouse (db/db) splinted wound healing model. Each Aim of our approach isolates an individual material property to simplify the investigation. For example, pore geometry impact is investigated using a single hydrogel formulation and hydrogel formulation impact uses a single pore geometry (constant formulation and pore geometry taken from our successful non-diabetic studies). If successful, this project will provide a better understanding of tissue response to a new class of biomaterial and produce an inexpensive and effective scaffold treatment option for accelerating diabetic wound closure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
  • 批准号:
    10297936
  • 项目类别:
  • 资助金额:
    $64.44万
  • 财政年份:
    2021
  • 负责人:
    Donald Richieri Griffin
  • 依托单位:
Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
  • 批准号:
    10657614
  • 项目类别:
  • 资助金额:
    $63.04万
  • 财政年份:
    2021
  • 负责人:
    Donald Richieri Griffin
  • 依托单位:
Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
  • 批准号:
    10161123
  • 项目类别:
  • 资助金额:
    $14.69万
  • 财政年份:
    2020
  • 负责人:
    Donald Richieri Griffin
  • 依托单位:
VEGF Gradients in Porous Hydrogels for Therapeutic Angiogenesis
海外基金